Your browser doesn't support javascript.
COVID-19 and Extracellular Vesicles: An Intriguing Interplay.
Pocsfalvi, Gabriella; Mammadova, Ramila; Ramos Juarez, Ana Paulina; Bokka, Ramesh; Trepiccione, Francesco; Capasso, Giovambattista.
  • Pocsfalvi G; Extracellular Vesicles and Mass Spectrometry Laboratory, Institute of Biosciences and BioResources, National Research Council of Italy, Naples, Italy, gabriella.pocsfalvi@ibbr.cnr.it.
  • Mammadova R; Extracellular Vesicles and Mass Spectrometry Laboratory, Institute of Biosciences and BioResources, National Research Council of Italy, Naples, Italy.
  • Ramos Juarez AP; Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Bokka R; Extracellular Vesicles and Mass Spectrometry Laboratory, Institute of Biosciences and BioResources, National Research Council of Italy, Naples, Italy.
  • Trepiccione F; Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Capasso G; Extracellular Vesicles and Mass Spectrometry Laboratory, Institute of Biosciences and BioResources, National Research Council of Italy, Naples, Italy.
Kidney Blood Press Res ; 45(5): 661-670, 2020.
Article in English | MEDLINE | ID: covidwho-781259
ABSTRACT

BACKGROUND:

The outbreak of severe acute respiratory syndrome ß-coronavirus 2 (SARS-CoV-2) has the potential to become a long-lasting global health crisis. The number of people infected with the novel coronavirus has surpassed 22 million globally, resulting in over 700,000 deaths with more than 15 million people having recovered (https//covid19.who.int). Enormous efforts are underway for rapid vaccine and treatment developments. Amongst the many ways of tackling the novel coronavirus disease 2019 (COVID-19) pandemic, extracellular vesicles (EVs) are emerging.

SUMMARY:

EVs are lipid bilayer-enclosed structures secreted from all types of cells, including those lining the respiratory tract. They have established roles in lung immunity and are involved in the pathogenesis of various lung diseases, including viral infection. In this review, we point out the roles and possible contribution of EVs in viral infections, as well as ongoing EV-based approaches for the treatment of COVID-19, including clinical trials. Key Messages EVs share structural similarities to viruses and recent findings demonstrate that viruses exploit EVs for cellular exit and EVs exploit viral entry mechanisms for cargo delivery. Moreover, EV-virus interplay could be exploited for future antiviral drug and vaccine development. EV-based therapies, especially the mesenchymal stem cell-derived EVs, are being intensively studied for the treatment of COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Extracellular Vesicles / Betacoronavirus / Lung Diseases Type of study: Prognostic study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Kidney Blood Press Res Journal subject: Nephrology Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Extracellular Vesicles / Betacoronavirus / Lung Diseases Type of study: Prognostic study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Kidney Blood Press Res Journal subject: Nephrology Year: 2020 Document Type: Article